Soligenix, Inc. collaborated with John A. Burns School of Medicine on vaccine development relevant for virus-endemic countries in Africa.
Steady: 0 in the last 7 days
Updated nov 11
The latest in this situation
- IVI's Sahastrabuddhe discusses vaccine preparedness across West Africa and South Asia.
- MMV is conducting clinical trials in Rwanda while WHO reports on malaria cases across Africa.
- CEPI provided support for the Tumaini trial, where a Merck vaccine is being administered in the Democratic Republic of the Congo.
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Soligenix, Inc. collaborated with John A. Burns School of Medicine on vaccine development relevant for virus-endemic countries in Africa.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Vaccine trials are being conducted in Africa, alongside WHO estimates of the disease burden.Sub-event
Soligenix and a medical school announced a collaboration on vaccine development for Africa.1 source
Keep exploring
The entities involved
-
John A. Burns School of Medicine
medical school of the University of Hawai‘i at Mānoa
Nothing else this week.
-
Africa
continent